Mounjaro is newer than Ozempic and Wegovy, but it's already changing the weight loss landscape in the UK. Trial data suggests it delivers superior weight loss than semaglutide alone. This guide explains what Mounjaro is, how it differs, and how to access it in the UK.
What Is Mounjaro?
Mounjaro is the brand name for tirzepatide, manufactured by Eli Lilly. It's a dual GIP/GLP-1 receptor agonist - meaning it activates two hormones, not just one.
Key facts:
- Licensed in the UK (2023) for type 2 diabetes; weight loss indication pending EMA decision
- Once-weekly injection, same as Ozempic/Wegovy
- Higher weight loss rates than semaglutide in clinical trials
- Currently available via private clinics; not yet NHS-standard
- Costs £150-250/month privately in the UK
GIP + GLP-1: Why Two Hormones Are Better
Semaglutide (Ozempic/Wegovy) targets GLP-1 only. Mounjaro targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide).
What GIP Does
- Increases satiety (feeling of fullness)
- Reduces appetite separately from GLP-1
- May have minor effects on energy expenditure (though this is debated)
The Combined Effect
Having both hormones active simultaneously produces additive appetite suppression. The result: greater weight loss on Mounjaro than on semaglutide alone at equivalent doses.
Mounjaro vs Semaglutide: Trial Data
STEP Trials (Semaglutide for weight loss)
- Average weight loss on Wegovy 2.4 mg: 15-22% body weight
- Typical loss: 14-20 kg over 1 year
SURMOUNT Trials (Tirzepatide for weight loss)
- Average weight loss on Mounjaro 15 mg: 20-22% body weight
- Typical loss: 18-20 kg over 1 year
- Faster weight loss trajectory (reaches plateau sooner)
Real-world UK experience: Patients report faster weight loss in first 3-4 months on Mounjaro, though long-term data is still accumulating.
Dosing & Titration
| Aspect | Details |
|---|---|
| Starting dose | 2.5 mg/week |
| Titration | Increases by 2.5 mg every 4 weeks |
| Maximum dose | 15 mg/week |
| Timeline to max | 16 weeks (same as Wegovy) |
| Available doses | 2.5, 5, 7.5, 10, 12.5, 15 mg |
Most UK private clinics titrate to 10-15 mg for maximum weight loss, though some patients plateau at 7.5-10 mg.
UK Availability
Private Clinics
Mounjaro is increasingly available through premium UK private clinics:
- Numan - offers tirzepatide
- Juniper - offers tirzepatide
- Manual - offers tirzepatide
- Oviva - expanding tirzepatide access
- Liva Healthcare - offers tirzepatide
Typically:
- Cost: £200-250/month
- Access: 1-2 weeks
- Monitoring: Regular check-ins, bloodwork
Prices and what they include vary a lot, so it pays to compare clinics on dose, monitoring and total monthly cost before you sign up.
See our full private clinic comparison
NHS
Mounjaro is licensed for type 2 diabetes in the UK but is rarely prescribed on the NHS for weight loss - availability varies by ICB (Integrated Care Board). Some NHS trusts are piloting it; most are not yet. If you want Mounjaro, private is currently your only realistic option.
Side Effects: Similar to Semaglutide, Maybe Slightly More
Mounjaro side effect profile is broadly similar to semaglutide:
| Side Effect | Incidence | Notes |
|---|---|---|
| Nausea | 40-50% | Usually peaks weeks 2-8, improves |
| Constipation | 20-30% | Fibre and hydration help |
| Diarrhoea | 10-20% | Less common but possible |
| Fatigue | 10-15% | Usually temporary |
| Hair loss | 5-10% | Temporary telogen effluvium |
Important caveat: Tirzepatide trials show slightly higher nausea rates than semaglutide at equivalent dose ranges. If you're nausea-sensitive, this may matter.
Full guide to managing GLP-1 side effects
Managing the early side effects
Because tirzepatide can bring slightly more nausea early on, plus the usual constipation, a couple of gentle supports can smooth the first few weeks alongside small meals and plenty of fluids.
Ginger 1000mg 120 Tablets
High-strength ginger root tablets, a four-month supply. Ginger has the strongest evidence of any natural remedy for the nausea most people get in the first weeks on a GLP-1.
Ad | Amazon Associate
Zipvit Magnesium Glycinate 2000mg
Gentle, highly absorbable magnesium glycinate that eases GLP-1 constipation without the cramping of harsher laxatives, and supports calmer sleep during rapid weight loss.
Ad | Amazon Associate
Some links above are affiliate links. If you buy through them we may earn a small commission, at no extra cost to you. It never changes what we recommend.
Cost Comparison: Mounjaro vs Ozempic vs Wegovy
| Medication | Typical Private Cost | Max Dose | Expected Weight Loss |
|---|---|---|---|
| Ozempic | £150-200/month | 1.0 mg | 8-15% |
| Wegovy | £180-250/month | 2.4 mg | 15-22% |
| Mounjaro | £200-250/month | 15 mg | 20-22% |
For most people: Mounjaro is cost-similar to Wegovy but may deliver slightly faster/greater weight loss. Whether that's worth it is personal.
Who Should Consider Mounjaro?
Good candidates:
- Want maximum weight loss (trials suggest Mounjaro edges out semaglutide)
- Have tried semaglutide and plateaued (some non-responders to semaglutide respond to tirzepatide)
- Type 2 diabetic seeking dual benefits (weight loss + glucose control)
- Can afford £200-250/month indefinitely
- Don't mind being on a "newer" drug (tirzepatide has 3-4 years real-world data vs. semaglutide's 8+ years)
Caution or skip:
- Nausea-sensitive and worried about slightly higher nausea rates
- Pancreatitis history (rare, but both drugs carry risk)
- Personal/family history of MTC or MEN2 (black box warning applies)
- Pregnancy planned (contraindicated)
See our full thyroid safety guide
Semaglutide vs Tirzepatide: Which to Start?
Start with Semaglutide (Ozempic) if:
- Budget-conscious (slightly cheaper)
- Want to "test" GLP-1 tolerance before committing
- Prefer a drug with 8+ years real-world data
- Have mild nausea concerns
Start with Tirzepatide (Mounjaro) if:
- Want maximum weight loss from the outset
- Have access via a good private clinic
- Don't mind paying premium cost
- Previous semaglutide non-responder (seek clinic advice first)
Many UK patients:
- Start Ozempic for cost and simplicity
- Escalate to Mounjaro if they plateau or want more aggressive weight loss
What About NHS Access?
Mounjaro for weight loss is not yet standard NHS. A few pilot schemes exist in specific regions, but waiting lists are even longer than for Wegovy. Unless you live in a very specific NHS trust piloting tirzepatide, private is your option.
Check NHS GLP-1 eligibility for your region
Key Takeaway
Mounjaro (tirzepatide) is a legitimate upgrade to semaglutide with trial evidence for superior weight loss. It's more expensive and slightly newer, but it's increasingly accessible via UK private clinics. If cost is no object and you want maximum weight loss, Mounjaro is worth considering.
Next Steps
- Compare UK private GLP-1 clinics offering Mounjaro
- Understanding GLP-1 side effects
- Nutrition strategy on GLP-1/tirzepatide
- Mounjaro vs Ozempic vs Wegovy detailed comparison
As an Amazon Associate I earn from qualifying purchases.
Disclaimer: This is educational information, not medical advice. Always consult your GP or prescriber before starting tirzepatide or other GLP-1 medications.